Chad Stiening

Chad Stiening is the CEO and co-founder of Kypha. Chad has also previously worked with Common Place Holdings, Nucleus: Kentucky's Life Sciences and Innovation Center, LLC, and the Cardiovascular Innovation Institute (UofL). Stiening has been in the business industry for many years and has gained a wealth of knowledge and experience in different areas. Chad is a well-rounded individual with a passion for helping others and making a difference in the world.

Chad Stiening has a post-doctoral degree in biomedical engineering from the University of Arizona. Chad's PhD is in animal science with a focus on molecular genetics from the same school. Chad also has a BS in biology and finance from the University of Illinois Urbana-Champaign.

Some direct reports include Niamh O’Luanaigh - COO, Martin Schmidt - Chief Scientific Officer.